The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Privia Health Group Inc. shares valued at $2,376,834 were sold by Mehrotra Parth on Sep 20. At $37.31 per share, Mehrotra Parth sold 63,705 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the completion of this transaction.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now. .
Also, Mehrotra Parth sold 66,011 shares, netting a total of over 2,462,210 in proceeds. Following the sale of shares at $37.30 each, the insider now holds 97,391 shares.
Before that, Mehrotra Parth had sold 107,702 shares from its account. In a trade valued at $4,072,758, the President and COO traded Privia Health Group Inc. shares for $37.82 each. Upon closing the transaction, the insider’s holdings decreased to 107,702 shares, worth approximately $0.0.
Analysts at BofA Securities started covering the stock with ‘”a Buy”‘ outlook in a report released in early May. As of April 28, 2022, BTIG Research has initiated its “Buy” rating for PRVA.
Analyzing PRVA’s Price Performance
On Thursday, Privia Health Group Inc. [NASDAQ: PRVA] plunged -6.35% to $34.66. The stock’s lowest price that day was $33.28, but it reached a high of $37.02 in the same session. During the last five days, there has been a drop of approximately -17.52%. Over the course of the year, Privia Health Group Inc. shares have jumped approximately 33.98%. Shares of the company reached a 52-week high of $44.64 on 08/24/22 and a 52-week low of $17.99 on 05/12/22. A 50-day SMA is recorded $38.08, while a 200-day SMA reached $28.17. Nevertheless, trading volume fell to 2.46 million shares from 0.81 million shares the previous day.
Support And Resistance Levels for Privia Health Group Inc. (PRVA)
According to the 24-hour chart, there is a support level at 32.95, which, if violated, would cause prices to drop to 31.25. In the upper region, resistance lies at 36.69. The next price resistance is at 38.73. RSI (Relative Strength Index) is 37.29 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -3.49, which suggests the price will decrease in the coming days. Percent R is at 86.94%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
Is Privia Health Group Inc. subject to short interest?
Stocks of Privia Health Group Inc. saw a sharp steep in short interest on Jul 14, 2022 dropping by -0.18 million shares to 1.98 million. Data from Yahoo Finance shows that the short interest on Jun 14, 2022 was 2.16 million shares. A decline of -9.09% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 1.84 of the overall float, the days-to-cover ratio (short ratio) decline to 1.84.
Which companies own the most shares of Privia Health Group Inc. (PRVA)?
According to Goldman Sachs & Co. LLC filings, the company currently owns 27,913,369 shares, which is about 25.70% of the total PRVA shares outstanding. The investor’s shares have plunged by -97,088 from its previous 13-F filing of 28010457.0 shares. With the completion of the buy transaction, The Vanguard Group, Inc.’s stake is now worth $174,320,269. Newton Investment Management Nort reduced a -5.06% interest valued at $147.49 million while T. Rowe Price Associates, Inc. purchased a 1,162,270 stake. A total of 186,923 shares of Privia Health Group Inc. were bought by BlackRock Fund Advisors during the quarter, and -58,428 were sold by Riverbridge Partners LLC. In its current portfolio, Senator Investment Group LP holds 1,500,000 shares valued at $59.69 million.
In terms of Privia Health Group Inc. share price expectations, FactSet research, analysts set an average price target of $46.83 in the next 12 months, up nearly 22.94% from the previous closing price of $37.01. Analysts anticipate Privia Health Group Inc. stock to reach $58.00 by 2022, with the lowest price target being $35.00. In spite of this, 13 analysts ranked Privia Health Group Inc. stock as a Buy at the end of 2022. On March 30, 2022, Guggenheim assigned a price target of “a Buy” to the stock and initiated coverage with a $35.